These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20067707)

  • 21. Exploring novel approaches to vaginal drug delivery.
    Gupta S; Gabrani R; Ali J; Dang S
    Recent Pat Drug Deliv Formul; 2011 May; 5(2):82-94. PubMed ID: 21413924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucoadhesive tablets for the vaginal delivery of progesterone: in vitro evaluation and pharmacokinetics/pharmacodynamics in female rabbits.
    Hassan AS; Soliman GM; Ali MF; El-Mahdy MM; El-Gindy GEA
    Drug Dev Ind Pharm; 2018 Feb; 44(2):224-232. PubMed ID: 28956650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The vagina as a route for systemic drug delivery.
    Hussain A; Ahsan F
    J Control Release; 2005 Mar; 103(2):301-13. PubMed ID: 15763615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic potential of mucoadhesive drug delivery systems--an updated patent review.
    Maurya SK; Pathak K; Bali V
    Recent Pat Drug Deliv Formul; 2010 Nov; 4(3):256-65. PubMed ID: 20649509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Freeze-Dried Matrices Based on Polyanion Polymers for Chlorhexidine Local Release in the Buccal and Vaginal Cavities.
    Giordani B; Abruzzo A; Musazzi UM; Cilurzo F; Nicoletta FP; Dalena F; Parolin C; Vitali B; Cerchiara T; Luppi B; Bigucci F
    J Pharm Sci; 2019 Jul; 108(7):2447-2457. PubMed ID: 30853513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaginal drug delivery system: A promising route of drug administration for local and systemic diseases.
    Subi MTM; Selvasudha N; Vasanthi HR
    Drug Discov Today; 2024 Jun; 29(6):104012. PubMed ID: 38705512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug delivery by the intravaginal route.
    Woolfson AD; Malcolm RK; Gallagher R
    Crit Rev Ther Drug Carrier Syst; 2000; 17(5):509-55. PubMed ID: 11108158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin.
    Hombach J; Palmberger TF; Bernkop-Schnürch A
    J Pharm Sci; 2009 Feb; 98(2):555-64. PubMed ID: 18563796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced topical drug delivery system for the management of vaginal candidiasis.
    Johal HS; Garg T; Rath G; Goyal AK
    Drug Deliv; 2016; 23(2):550-63. PubMed ID: 24959937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of an in vitro mucoadhesion testing method for vaginal semisolids: influence of different testing conditions and instrumental parameters.
    das Neves J; Amaral MH; Bahia MF
    Eur J Pharm Biopharm; 2008 Jun; 69(2):622-32. PubMed ID: 18248972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liposomal gels for vaginal drug delivery.
    Pavelić Z; Skalko-Basnet N; Schubert R; Jalsenjak I
    Methods Enzymol; 2004; 387():287-99. PubMed ID: 15172171
    [No Abstract]   [Full Text] [Related]  

  • 32. Gels as vaginal drug delivery systems.
    das Neves J; Bahia MF
    Int J Pharm; 2006 Aug; 318(1-2):1-14. PubMed ID: 16621366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucoadhesive drug delivery systems.
    Hombach J; Bernkop-Schnürch A
    Handb Exp Pharmacol; 2010; (197):251-66. PubMed ID: 20217533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaginal distribution and retention of a multiparticulate drug delivery system, assessed by gamma scintigraphy and magnetic resonance imaging.
    Mehta S; Verstraelen H; Peremans K; Villeirs G; Vermeire S; De Vos F; Mehuys E; Remon JP; Vervaet C
    Int J Pharm; 2012 Apr; 426(1-2):44-53. PubMed ID: 22265911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoparticle-releasing nanofiber composites for enhanced in vivo vaginal retention.
    Krogstad EA; Ramanathan R; Nhan C; Kraft JC; Blakney AK; Cao S; Ho RJY; Woodrow KA
    Biomaterials; 2017 Nov; 144():1-16. PubMed ID: 28802690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a mucoadhesive delivery system for control release of doxepin with application in vaginal pain relief associated with gynecological surgery.
    Sanz R; Clares B; Mallandrich M; Suñer-Carbó J; Montes MJ; Calpena AC
    Int J Pharm; 2018 Jan; 535(1-2):393-401. PubMed ID: 29146542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucoadhesive therapeutic compositions: a patent review (2011-2014).
    Laffleur F
    Expert Opin Ther Pat; 2016; 26(3):377-88. PubMed ID: 26796750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of recent patents on composition of mucoadhesive drug delivery systems.
    Bruschi ML; de Francisco LM; S de Toledo Lde A; Borghi FB
    Recent Pat Drug Deliv Formul; 2015; 9(1):79-87. PubMed ID: 25420876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake.
    Ensign LM; Hoen TE; Maisel K; Cone RA; Hanes JS
    Biomaterials; 2013 Sep; 34(28):6922-9. PubMed ID: 23769419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced mucosal and systemic immune responses to a vaginal vaccine coadministered with RANTES-expressing plasmid DNA using in situ-gelling mucoadhesive delivery system.
    Oh YK; Park JS; Yoon H; Kim CK
    Vaccine; 2003 May; 21(17-18):1980-8. PubMed ID: 12706687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.